Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
TGA:14
Drug Approvals
DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial (428033)
- Product Name
- DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial
- Approval Date
- Mar 24, 2025
TGA
DEXRAZOXANE-REACH dexrazoxane 500 mg powder for injection for infusion vial (428034)
- Product Name
- DEXRAZOXANE-REACH dexrazoxane 500 mg powder for injection for infusion vial
- Approval Date
- Mar 24, 2025
TGA
FUROSEMIDE-REACH furosemide 20 mg/2 mL solution for injection ampoule (421677)
- Product Name
- FUROSEMIDE-REACH furosemide 20 mg/2 mL solution for injection ampoule
- Approval Date
- Feb 12, 2025
TGA
NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial (405072)
- Product Name
- NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial
- Approval Date
- Apr 3, 2024
TGA
CYCLOPHOSPHAMIDE-REACH cyclophosphamide (as monohydrate) 1000 mg powder for injection vial (394171)
- Product Name
- CYCLOPHOSPHAMIDE-REACH cyclophosphamide (as monohydrate) 1000 mg powder for injection vial
- Approval Date
- Jul 28, 2023
TGA
CYCLOPHOSPHAMIDE-REACH cyclophosphamide (as monohydrate) 500 mg powder for injection vial (394170)
- Product Name
- CYCLOPHOSPHAMIDE-REACH cyclophosphamide (as monohydrate) 500 mg powder for injection vial
- Approval Date
- Jul 28, 2023
TGA
CARBOPROST-REACH carboprost (as trometamol) 250 microgram/1mL solution for injection vial (394092)
- Product Name
- CARBOPROST-REACH carboprost (as trometamol) 250 microgram/1 mL solution for injection vial
- Approval Date
- Jun 30, 2023
TGA
ROMIDEPSIN-REACH 10mg powder for injection vial, and solvent for reconstitution vial (382687)
- Product Name
- ROMIDEPSIN-REACH romidepsin 10 mg powder for injection vial, and solvent for reconstitution vial
- Approval Date
- Dec 13, 2022
TGA
FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial (372680)
- Product Name
- FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial
- Approval Date
- Oct 19, 2022
TGA
THIOTEPA-REACH thiotepa 15 mg powder for injection vial (364527)
- Product Name
- THIOTEPA-REACH thiotepa 15 mg powder for injection vial
- Approval Date
- Jun 14, 2022
TGA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found